Matches in Wikidata for { <http://www.wikidata.org/entity/Q61651898> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q61651898 description "article scientifique publié en 2018" @default.
- Q61651898 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q61651898 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61651898 description "scientific article published on 28 October 2018" @default.
- Q61651898 description "wetenschappelijk artikel" @default.
- Q61651898 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q61651898 description "գիտական հոդված հրատարակված 2018 թվականի հոկտեմբերի 28-ին" @default.
- Q61651898 name "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 name "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 type Item @default.
- Q61651898 label "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 label "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 prefLabel "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 prefLabel "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 P1433 Q61651898-32545B98-3DDE-4900-9CC3-B8DA91682EE9 @default.
- Q61651898 P1476 Q61651898-46052ACF-CCA3-439F-9E09-6BFD2C0A5F8F @default.
- Q61651898 P2093 Q61651898-08EE80E8-6EF4-4FC0-AE57-746B0D2B0724 @default.
- Q61651898 P2093 Q61651898-09235BD4-285E-430D-861C-339A6CFB9688 @default.
- Q61651898 P2093 Q61651898-2641938C-DBCE-4712-8A0A-9C81828214F6 @default.
- Q61651898 P2093 Q61651898-3961E66B-E4DF-42A1-94BE-2730CB7896F5 @default.
- Q61651898 P2093 Q61651898-3D77E77E-560D-4C13-93CC-E2B64FF665B0 @default.
- Q61651898 P2093 Q61651898-697B3328-9A88-4E02-AE00-FF6744DE92D4 @default.
- Q61651898 P2093 Q61651898-753707F3-4EEA-46C9-9632-CB44EF245AFB @default.
- Q61651898 P2093 Q61651898-7AA410FE-8912-4218-9539-568522A89BFC @default.
- Q61651898 P2093 Q61651898-8D73B062-D96A-4039-A100-55EEFFB1AFD1 @default.
- Q61651898 P2093 Q61651898-A1BE152D-5379-4F15-9206-2BC430B4F7DB @default.
- Q61651898 P2093 Q61651898-AA6578D6-6ECF-4DBA-AFA0-0D73827CA091 @default.
- Q61651898 P2093 Q61651898-AB5B0DD8-EBAF-4FC7-8A0E-7706B77F1425 @default.
- Q61651898 P2093 Q61651898-B0E94453-1A00-4BC9-96AB-CE74CEC2ED2D @default.
- Q61651898 P2093 Q61651898-C2330CC6-655F-4837-8438-47B580124F0A @default.
- Q61651898 P304 Q61651898-F2BFF14D-F54A-4E5F-A5C7-81BF74837C0B @default.
- Q61651898 P31 Q61651898-02114ABA-8CB9-4A26-8706-FAB94FB11137 @default.
- Q61651898 P356 Q61651898-5069F1DE-8D37-4EEC-B13C-EBBAE1DF250E @default.
- Q61651898 P407 Q61651898-BAF1064E-12CE-405C-A373-4302715ABD68 @default.
- Q61651898 P433 Q61651898-FC5A69A5-DB6F-407E-BA2A-F3F79D670976 @default.
- Q61651898 P478 Q61651898-256F19F7-F5C3-40A0-B252-259C203C3FA2 @default.
- Q61651898 P50 Q61651898-5AEEA907-935D-4094-8BF5-48AE3DB0C8C3 @default.
- Q61651898 P50 Q61651898-6580C046-6BFE-443E-A9BE-7CA9B28F6D63 @default.
- Q61651898 P50 Q61651898-C06A84A6-A28A-44A4-BCDD-F3C124D18F2E @default.
- Q61651898 P577 Q61651898-D8473034-68EA-4CEA-AD8E-54716ADC766A @default.
- Q61651898 P698 Q61651898-C9432FA1-EA5A-4627-9652-EE9E64C5CFC4 @default.
- Q61651898 P921 Q61651898-40653F54-ADDF-43CF-B535-0D76D1808F11 @default.
- Q61651898 P921 Q61651898-DF0F8D55-051A-4AA1-87D5-10FA5A44EB09 @default.
- Q61651898 P356 BJD.16717 @default.
- Q61651898 P698 29727479 @default.
- Q61651898 P1433 Q4970191 @default.
- Q61651898 P1476 "A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)" @default.
- Q61651898 P2093 "A P Jones" @default.
- Q61651898 P2093 "A Rosala-Hallas" @default.
- Q61651898 P2093 "C Spowart" @default.
- Q61651898 P2093 "C Walker" @default.
- Q61651898 P2093 "F Ashoor" @default.
- Q61651898 P2093 "F Browne" @default.
- Q61651898 P2093 "L O'Neill" @default.
- Q61651898 P2093 "M Wan" @default.
- Q61651898 P2093 "N Webb" @default.
- Q61651898 P2093 "P Beattie" @default.
- Q61651898 P2093 "P Williamson" @default.
- Q61651898 P2093 "S Baron" @default.
- Q61651898 P2093 "T Sach" @default.
- Q61651898 P2093 "TREAT Trial Investigators" @default.
- Q61651898 P304 "1297-1306" @default.
- Q61651898 P31 Q13442814 @default.
- Q61651898 P356 "10.1111/BJD.16717" @default.
- Q61651898 P407 Q1860 @default.
- Q61651898 P433 "6" @default.
- Q61651898 P478 "179" @default.
- Q61651898 P50 Q39066910 @default.
- Q61651898 P50 Q55277361 @default.
- Q61651898 P50 Q87806023 @default.
- Q61651898 P577 "2018-10-28T00:00:00Z" @default.
- Q61651898 P698 "29727479" @default.
- Q61651898 P921 Q367700 @default.
- Q61651898 P921 Q422232 @default.